Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-13 Sale | 2026-01-15 4:22 pm | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 27,000 | $19.7 | $531,828 | 114,995 (Direct) | View |
| 2023-01-03 Purchase | 2023-01-04 08:30 am | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 10,000 | $0 | $0 | 15,000 (Direct) | View |
| 2021-06-18 Purchase | 2021-06-21 11:03 am | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 8,000 | $4.75 | $38,000 | 30,000 (Direct) | View |
| 2021-04-26 Purchase | 2021-04-27 4:02 pm | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 12,000 | $5 | $60,000 | 22,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-01 Exercise | 2026-03-03 4:44 pm | N/A 2035-02-17 | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 3,542 | $0 | 192,408 (Direct) | View |
| 2026-03-01 Exercise | 2026-03-03 4:44 pm | N/A N/A | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 3,542 | $4.38 | 192,408 (Direct) | View |
| 2026-02-17 Option Award | 2026-02-19 4:38 pm | N/A 2036-02-16 | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 110,000 | $0 | 110,000 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 4:23 pm | N/A 2035-02-17 | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 3,541 | $0 | 192,408 (Direct) | View |
| 2026-02-01 Exercise | 2026-02-03 4:23 pm | N/A N/A | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 3,541 | $4.38 | 192,408 (Direct) | View |
| 2026-01-16 Exercise | 2026-01-21 4:20 pm | N/A 2035-02-17 | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 3,542 | $0 | 192,408 (Direct) | View |
| 2026-01-16 Exercise | 2026-01-21 4:20 pm | N/A N/A | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 3,542 | $4.38 | 192,408 (Direct) | View |
| 2026-01-13 Exercise | 2026-01-15 4:22 pm | N/A 2034-04-16 | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 27,000 | $0 | 114,995 (Direct) | View |
| 2026-01-13 Exercise | 2026-01-15 4:22 pm | N/A N/A | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 27,000 | $8.39 | 114,995 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 7:27 pm | 2027-01-02 2036-01-02 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2025-08-18 Exercise | 2025-08-19 4:01 pm | N/A N/A | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 17,557 | $1.09 | 27,557 (Direct) | View |
| 2025-08-18 Exercise | 2025-08-19 4:01 pm | 2021-04-01 2031-03-30 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 17,557 | $0 | 27,557 (Direct) | View |
| 2025-06-24 Option Award | 2025-06-25 5:30 pm | N/A 2035-06-24 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2025-02-25 Option Award | 2025-02-25 9:30 pm | N/A 2035-02-25 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2025-02-18 Option Award | 2025-02-20 4:19 pm | N/A 2035-02-17 | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2025-01-01 Option Award | 2025-01-03 9:31 pm | 2026-01-01 2035-01-01 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 5,000 | $0 | 5,000 (Direct) | View |
Ownership | 2024-09-25 4:45 pm | N/A N/A | BioAge Labs Inc. | BIOA | GOLDSTEIN DOV A MD Chief Financial Officer | 0 | $0 | 270,326 (Direct) | View |
| 2024-06-24 Option Award | 2024-06-26 9:30 pm | N/A 2034-06-24 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2024-01-01 Option Award | 2024-01-19 6:30 pm | 2025-01-01 2034-01-01 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-26 4:38 pm | N/A 2033-06-23 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
Ownership | 2022-12-28 8:38 pm | 2021-04-01 2031-03-30 | Coya Therapeutics Inc. | COYA | GOLDSTEIN DOV A MD Director | 0 | $0 | 17,557 (Direct) | View |
| 2022-09-20 Option Award | 2022-09-22 4:10 pm | N/A 2032-09-20 | Gain Therapeutics Inc. | GANX | GOLDSTEIN DOV A MD Director | 10,500 | $0 | 10,500 (Direct) | View |
| 2022-09-09 Option Award | 2022-09-12 5:00 pm | N/A 2032-09-09 | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 37,600 | $0 | 37,600 (Direct) | View |
| 2021-08-19 Option Award | 2021-09-17 4:17 pm | N/A 2031-08-19 | NeuBase Therapeutics Inc. | NBSE | GOLDSTEIN DOV A MD Director | 38,135 | $0 | 38,135 (Direct) | View |